Interferon-Gamma-Dependent/Independent Expression of Indoleamine 2,3-Dioxygenase
References
Bajetta, E., Del Vecchio, M., Mortarini, R., Nadeau, R., Rakhit, A., Rimassa, L., Fowst, C., Borri, A., Anichini, A., and Parmiani, G. 1998, Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanoma, Clin. Cancer Res. 4:75–85.
Brown, R.R. 1996, Metabolism and Biology of Tryptophan, in: Recent Advances in Tryptophan Research (G.F. Filippini et al., eds.), pp. 15–25, Plenum Press, New York.
Byrne, G.I., Lehmann, L.K., Kirschbaum, J.G., Borden, E.C., Lee, C.M., and Brown, R.R. 1986, Induction of tryptophan degradation in vitro and in vivo: A γ-interferon-stimulated activity, J. Interferon Res. 6:389–396.
Dalton, D.K., Pitts, M.S., Keshav, S., Figari, I.S., and Stewart, T.A. 1993, Multiple defects of immune cell function in mice with disrupted interferon-γ genes, Science 259:1739–1742.
Habara-Ohkubo, A., Takikawa, O., and Yoshida, R. 1993, Establishment of an antitoxoplasma state by stable expression of mouse indoleamine 2,3-dioxygenase, Infect. Immun. 53:1810–1813.
Hayaishi, O., Takikawa, O., and Yoshida, R. 1990, Indoleamine 2,3-dioxygenase: Properties and function of a Superoxide utilizing enzyme in: Progress in Inorganic Chemistry: Bioinorganic Chemistry (S.J. Lippard, ed.), Vol. 38, pp. 75–95, John Wiley and Sons, Inc., New York.
Leonard, J.P., Sherman, M.L., Fisher, G.L., Buchanan, L.J., Larsen, G., Atkins, M.B., Sosman, J.A., Dutcher, J.P., Volgelzang, N.J., and Ryan, J.L. 1997, Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production, Blood 90:2541–2548.
Motzer, R.J., Rakit, A., Schwartz, L.H., Olencki, T., Malone, T.M., Sandstrom, K., Nadeau, R., Parmar, H., and Bukowski, R. 1998, Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advance renal cell carcinoma, Clin. Cancer Res. 4:1183–1191.
Munn, D.H., Zhou, M., Attwood, J.T., Bondarev, I., Conway, S.J., Marshall, B., Brown, C., and Mellor, A.L. 1998, Prevention of allogeneic fetal rejection by tryptophan catabolism, Science, 281:1191–1193.
Okuda, S., Nishiyama, N., Saito, H., and Katsuki, H. 1996, Hydrogen peroxide-mediated neural cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine, Proc. Natl. Acad. Sci. USA 93:12553–12558.
Romani, L., Puccetti, P., and Bistoni, F. 1997, Interleukin-12 in infectious diseases, Clin. Microbiol. Rev. 10:611–636.
Schwarcz, R., Whetsell, W.O. Jr., and Mangano, R.M. 1983, Quinolinic acid: An endogenous metabolite that produces axon-sparing lesions in rat brain, Science 219:316–318.
Saito, K., Nowak, T.S., Markey, S.P., and Heyes, M.P. 1993, Mechanism of delayed increase in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia. J. Neurochem. 60:180–182.
Tagawa, Y., Sekikawa, K., and Iwakura, Y. 1997, Suppression of concanavalin A-induced hepatitis in IFN-γ-/-mice, but not in TNF-a-/-mice. J. Immunol. 159:1418–1428.
Takikawa, O., Habara-Ohkubo, A., and Yoshida, R. 1990, IFN-γ is the inducer of indoleamine 2,3-dioxyge-nase in allografted tumor cells undergoing rejection. J. Immunol. 145:1246–1250.
Takikawa, O., Yoshida, R., Kido, and Hayaishi, O. 1986, Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase, J. Biol. Chem. 258:3648–3653.
Torinchieri, G. 1998, Proinflammatory and immunoregulatory functions of interleukin-12, Int. Rev. Immunol. 16:365–396.
Yamazaki, F., Kuroiwa, T., Takikawa, O., and Kido, R. 1985, Human indolylamine 2,3-dioxygenase. Its tissue distribution and characterization of the placental enzyme. Biochem J. 230:635–638.
Yoshida, R., Nukiwa, T., Watanabe, Y., Fujiwara, M., Hirata, F., and Hayaishi, O. 1980, Regulation of indoleamine 2,3-dioxygenase activity in the small intestine and the epididymis of mice, Arch. Biochem. Biophys. 203:343–351.
Wood, A.M. and Truscott, R.J. W. 1994, Ultraviolet filter compounds in human lenses: 3-hydroxykynurenine glucoside formation, Vision Res. 34:1369–1374.